Research Article
Alteration of Angiopoietin-Like Protein 4 Levels in Serum or Urine Correlate with Different Biochemical Markers in Hyperlipidemia-Related Proteinuria
Table 5
Expression of ANGPTL4 in serum and urine in patients with HL (HL-Pro/HLN-Pro group) among the different TC classification groups.
| | Group () | TC () (mmol/l) | Serum ANGPTL4 (ng/ml) | Urine ANGPTL4/Cr (μg/g) |
| | HL-Pro group () | <4.48 (16) | 19.58 (17.99, 22.16) | 53.97 (49.07, 62.08) | | 4.48-5.81 (20) | 24.25 (16.33, 34.51) | 75.11 (52.05, 83.85) | | 5.81-6.77 (16) | 71.44 (45.65, 94.63) | 48.53 (40.51, 62.01) | | >6.77 (16) | 35.42 (20.00, 69.47) | 45.46 (42.51, 96.09) | | 26.160 | 10.697 | | <0.001 | 0.013 |
| | HL-NPro group () | <4.29 (16) | | 8.67 (8.04, 10.28) | | 4.29-5.40 (18) | | 10.16 (9.67, 10.99) | | 5.40-6.64 (18) | | 10.18 (9.34, 11.48) | | >6.64 (16) | | 12.46 (7.94, 22.26) | | 5.699 | 3.892 | | 0.002 | 0.273 |
|
|
